EP3661923
N-HETEROCYCLIC COMPOUNDS AS OREXIN 2 AGONISTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
:
EP einkaleyfi: Þýðing ekki lögð inn:
2.8.2018:
15.5.2024:
18762939.9
:
1.8.2038
:
N-HETEROCYCLIC COMPOUNDS AS OREXIN 2 AGONISTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
2.8.2018
15.5.2024
:
Takeda Pharmaceutical Company Limited:
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
:
KAJITA, Yuichi:
Fujisawa-shi Kanagawa 251-0012, JP
:
MIKAMI, Satoshi:
Fujisawa-shi Kanagawa 251-0012, JP
:
MIYANOHANA, Yuhei:
Fujisawa-shi Kanagawa 251-0012, JP
:
KOIKE, Tatsuki:
Fujisawa-shi Kanagawa 251-0012, JP
:
DAINI, Masaki:
Fujisawa-shi Kanagawa 251-0012, JP
:
OYABU, Norio:
Fujisawa-shi Kanagawa 251-0012, JP
:
OGINO, Masaki:
Fujisawa-shi Kanagawa 251-8555, JP
:
TAKEUCHI, Kohei:
Fujisawa-shi Kanagawa 251-0012, JP
:
ITO, Yoshiteru:
Fujisawa-shi Kanagawa 251-0012, JP
:
TOKUNAGA, Norihito:
Fujisawa-shi Kanagawa 251-0012, JP
:
SUGIMOTO, Takahiro:
Fujisawa-shi Kanagawa 251-0012, JP
:
MIYAZAKI,Tohru:
Fujisawa-shi Kanagawa 251-0012, JP
:
ODA, Tsuneo:
Fujisawa-shi Kanagawa 251-0012, JP
:
HOASHI, Yasutaka:
Fujisawa-shi Kanagawa 251-0012, JP
:
HATTORI,Yasushi:
Fujisawa-shi Kanagawa 251-0012, JP
:
IMAMURA, Keisuke:
Fujisawa-shi Kanagawa 251-0012, JP
:
2017150685:
3.8.2017:
JP
:
2017248495:
25.12.2017:
JP
:
JP2018029696:
2.8.2018
:
C07D 211/36, C07D 401/06, C07D 405/06, C07D 417/06, C07D 205/04, C07D 207/14, C07D 211/56, C07D 401/10, C07D 401/14, C07D 403/06, C07D 405/10, C07D 405/12, C07D 413/06, C07D 417/14, A61P 25/00, A61K 31/435